Here are 13 healthcare venture capital deals announced in the past month:
1. Ooda Health, a San Francisco-based healthcare payments startup, completed a $40.5 million funding round, led by Oak HC/FT and DFJ Venture Capital.
2. Palo Alto, Calif.-based cancer immunotherapy company Immune-Onc raised $33 million in Series B funding from Northern Light Venture Capital, Vivo Capital and the Stanford-StartX Fund.
3. Alydia Health, a Menlo Park, Calif.-based medical device company, raised $10 million in Series B funding led by the Global Health Investment Fund.
4. Tvardi Therapeutics, a Houston-based biopharmaceutical company focused on the development of STAT3 inhibitors, raised $9 million in Series A funding from undisclosed investors.
5. Galera Therapeutics, a Malvern, Pa.-based biotechnology company focused on the development of drugs targeting oxygen metabolic pathways with the potential to transform cancer radiotherapy, secured $150 million in a joint, oversubscribed Series C financing and royalty purchase agreement. The financing was led by Clarus.
6. New York City-based biotech startup MouSensor raised $3.3 million in seed funding co-led by imec.xpand and Alexandria Venture Investments.
7. Ceribell, a Mountain View, Calif.-based developer of a rapid response EEG system, completed a $35 million Series B financing led by Optimas Capital Partners Fund and The Rise Fund with participation by UCB and LivaNova.
8. Maven, a digital health startup and benefits platform focused on improving access to healthcare for women, raised $27 million in Series B funding led by Sequoia and Oak HC/FT.
9. Lyra Therapeutics, a Watertown, Mass.-based biotechnology company developing medicines designed to target ear, nose and throat diseases, raised $29.5 million in Series B funding led by Perceptive Advisors.
10. Proscia, a Philadelphia-based digital pathology startup, completed an $8.3 million Series A financing led by Flybridge Capital.
11. Cambridge, Mass.-based drug discovery startup KSQ Therapeutics raised $76 million in Series B funding led by Flagship Pioneering.
12. Akrevia Therapeutics, a Cambridge, Mass.-based immunotherapy company, raised $30 million in Series A funding led by F-Prime Capital Partners and Atlas Venture.
13. VelosBio, a San Diego-based biotechnology company focused on developing novel antibody-drug conjugates to treat hematological cancers and solid tumors, raised $58 million in Series A funding led by Arix Bioscience.
More articles on healthcare finance:
15 health systems with strong finances
Nurses call for Michigan hospital CEO to step down as possibility of bankruptcy looms
Dignity Health’s net income more than doubles
